recombinant interferon gamma
recombinant interferon gamma is a biological therapy with 15 clinical trials. Historical success rate of 76.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
7
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
71.4%
10 of 14 finished
28.6%
4 ended early
0
trials recruiting
15
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma
Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
Clinical Trials (15)
Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma
Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
Biological Therapy in Treating Patients With Prostate Cancer
Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors
Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer
Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer
Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma
Tumor Cell Vaccine in Treating Patients With Advanced Cancer
All 15 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 15